Research advances in the role of lymphocyte activation gene-3 in liver-related diseases / 临床肝胆病杂志
Journal of Clinical Hepatology
; (12): 977-981, 2021.
Article
em Zh
| WPRIM
| ID: wpr-875917
Biblioteca responsável:
WPRO
ABSTRACT
Immune checkpoint inhibitors (ICIs) therapy has shown broad prospects in the treatment of malignant tumors and infectious diseases, but problems encountered during application drive researchers to explore potential immune checkpoints. This article summarizes the research advances in the role of the new immune checkpoint lymphocyte activation gene-3 (LAG-3) in liver-related diseases, aiming to provide a reference for subsequent research. LAG-3 is expected to become the classic target of next-generation ICIs therapy and play a key role in immunotherapy for liver-related diseases.
Texto completo:
1
Base de dados:
WPRIM
Idioma:
Zh
Revista:
Journal of Clinical Hepatology
Ano de publicação:
2021
Tipo de documento:
Article